DYN Award Disclosure
Kerr Douglas · SEC Form 4 · Filed Oct 22, 2026
Award
Calculated transaction value
$0
Kerr Douglas Head Of R&d And CMO
DYN
Transaction date
Oct 20, 2026
Public filing date
Oct 22, 2026
Filing lag
Filed 2 days later
DYN daily price context
Close on/before transaction
$16.27
Oct 20, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock option (right to buy) on Common Stock
- Quantity / price
- 12,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001814189-26-000007
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Dyne Therapeutics, Inc. DYN | Award | Oct 20, 2026 | $0 |
| Dyne Therapeutics, Inc. DYN Current | Award | Oct 20, 2026 | $0 |